Premium
Tobacco use disorder and cardiovascular health
Author(s) -
Benowitz Neal L.,
Liakoni Evangelia
Publication year - 2022
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.15703
Subject(s) - smokeless tobacco , medicine , tobacco harm reduction , nicotine , smoking cessation , disease , nicotine replacement therapy , intensive care medicine , cigarette smoking , narrative review , environmental health , incidence (geometry) , pharmacotherapy , tobacco smoke , tobacco use , psychiatry , pathology , population , physics , optics
This narrative review examines the impact of cigarette smoking and the use of other tobacco and nicotine products on cardiovascular disease. Smoking increases the incidence of both acute and chronic cardiovascular diseases, and the harmful effects are substantially and relatively quickly reversible after quitting. Recommended cessation treatment includes offering pharmacotherapy, counseling which should emphasize the rapid risk reduction that occurs after quitting and adequate follow‐up contacts. Although most research on cardiovascular disease in relation to tobacco use has focused upon cigarette smoking, we also review available data related to other combustible tobacco products, smokeless tobacco, electronic nicotine delivery systems and second‐hand smoke. We discuss the implications of smoking on clinical management of patients with heart disease and newer developments with potential relevance to treatment of such patients.